Validation Study of the SAGIT® Instrument in Acromegaly

CompletedOBSERVATIONAL
Enrollment

227

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

September 3, 2018

Study Completion Date

September 3, 2018

Conditions
Acromegaly
Trial Locations (33)

2100

University Hospital, Dept of Endocrinology, Copenhagen

8000

Department of Clinical Medicine - The Department of Endocrinology and Diabetes, Aarhus C

13385

CHU de Marseille - Hôpital de la Timone, Marseille

15212

Endocrinology and Metabolism, Pittsburgh

20357

Endoc Zentrum Fûr Endokrine Tumoren, Hamburg

25018

Ospedaliera Spedali Civili di Brescia, Montichiari

26122

Private Clinique, Oldenburg

28046

University Hospital, Madrid

30322

The Emory Pituitary Center, Atlanta

31400

CHU Larrey, Toulouse

41013

University Hospital Virgen del Rocio, Seville

44195

Cleveland Clinic, Cleveland

45147

University Hospital, Essen

69677

Hopital Neuro-Cardiologique, Bron

90048

Cedars-Sinai Medical Center, Los Angeles

94275

Hopital de Bicêtre, Le Kremlin-Bicêtre

Unknown

CHU de Liège, Liège

University Hospital, São Paulo

Azienda Ospedaliero Universitar a Fedderico II, Naples

Azienda Ospedaliera di Padova, Padua

Azienda Ospedaliero Universitaria Pisana-Endcrinologia 2, Pisa

Radbound UMC, Nijmegen

University Hospital, Barcelona

Hospital de Condia(CHUS) RVA Ramon Baltar S/N, Santiago de Compostela

Aberdeen Royal Infirmary, Aberdeen

University Hospital, Cambridge

Université Hospital, Cardiff

Endocrinology and Metabolism Churchill Hospital, Oxford

21941-913

Federal University of Rio de Janeiro, Rio de Janeiro

0503900

University Hospital, São Paulo

00168

Endocrinology, University Hospital, Policlinica Gemelu, Rome

2333 2A

LUMC Leiden,, Leiden

3000 CA

Erasmus MC, Rotterdam

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY